Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sotalol 50mg/5ml oral solution
0204000T0AAAPAP
|
Sotalol hydrochloride | Sotalol hydrochloride | Cardiovascular System | No data available |
|
Sotalol 50mg/5ml oral suspension
0204000T0AABDBD
|
Sotalol hydrochloride | Sotalol hydrochloride | Cardiovascular System | No data available |
|
Sotalol 5mg/5ml oral solution
0204000T0AAAWAW
|
Sotalol hydrochloride | Sotalol hydrochloride | Cardiovascular System | No data available |
|
Sotalol 80mg/5ml oral liquid
0204000T0AAAUAU
|
Sotalol hydrochloride | Sotalol hydrochloride | Cardiovascular System | No data available |
|
Sotalol 8mg/5ml oral solution
0204000T0AABABA
|
Sotalol hydrochloride | Sotalol hydrochloride | Cardiovascular System | No data available |
|
Spironolactone 1.25mg/5ml oral liquid
0202030S0AADPDP
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 10mg / Chlorothiazide 100mg capsules
0202040S0AAANAN
|
Chlorothiazide/spironolactone | Spironolactone with thiazides | Cardiovascular System | No data available |
|
Spironolactone 10mg/5ml / Chlorothiazide 100mg/5ml liquid
0202040S0AAAJAJ
|
Chlorothiazide/spironolactone | Spironolactone with thiazides | Cardiovascular System | No data available |
|
Spironolactone 10mg/5ml / Chlorothiazide 250mg/5ml liquid
0202040S0AAAIAI
|
Chlorothiazide/spironolactone | Spironolactone with thiazides | Cardiovascular System | No data available |
|
Spironolactone 12.5mg/5ml oral liquid
0202030S0AADKDK
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 125mg/5ml oral liquid
0202030S0AACXCX
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 12mg/5ml oral liquid
0202030S0AADSDS
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 13.5mg/5ml oral liquid
0202030S0AADJDJ
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 16mg / Chlorothiazide 160mg capsules
0202040S0AAAQAQ
|
Chlorothiazide/spironolactone | Spironolactone with thiazides | Cardiovascular System | No data available |
|
Spironolactone 1mg / Chlorothiazide 10mg capsules
0202040S0AAAAAA
|
Chlorothiazide/spironolactone | Spironolactone with thiazides | Cardiovascular System | No data available |
|
Spironolactone 1mg / Chlorothiazide 10mg oral powder sachets
0202040S0AAABAB
|
Chlorothiazide/spironolactone | Spironolactone with thiazides | Cardiovascular System | No data available |
|
Spironolactone 2.5mg/5ml oral liquid
0202030S0AADADA
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 200mg/5ml oral liquid
0202030S0AADHDH
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 20mg/5ml / Chlorothiazide 200mg/5ml liquid
0202040S0AAAFAF
|
Chlorothiazide/spironolactone | Spironolactone with thiazides | Cardiovascular System | No data available |
|
Spironolactone 20mg/5ml oral liquid
0202030S0AADDDD
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 2mg/5ml oral liquid
0202030S0AADUDU
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 3.3mg/5ml oral liquid
0202030S0AADXDX
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 3.5mg/5ml oral liquid
0202030S0AADTDT
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 30mg/5ml oral liquid
0202030S0AACUCU
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
|
Spironolactone 35mg/5ml oral liquid
0202030S0AADGDG
|
Spironolactone | Spironolactone | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.